{"title":"危重患者输血与感染发生率之间的剂量-反应关系:系统回顾和剂量-反应荟萃分析。","authors":"Shodai Yoshihiro, Yuki Kataoka, Takashi Hongo, Takahiro Tsuge, Hiroaki Matsuo","doi":"10.1186/s40560-025-00822-x","DOIUrl":null,"url":null,"abstract":"<p><strong>Purpose: </strong>To estimate the association between red blood cell (RBC) transfusion volume and hospital-acquired infections (HAI) in critically ill patients, with a particular focus on identifying the potential threshold volumes at which infection risk changes.</p><p><strong>Methods: </strong>The MEDLINE, CENTRAL, Embase, and Transfusion Evidence Library databases were searched for studies published from database inception to November 2024. Citation searches and reference checks of the relevant guidelines were combined. Studies that evaluated transfusion and anemia pharmacotherapy in critically ill patients were included. Outcome of interest was the incidence of HAI. We conducted a dose-response meta-analysis (DRMA) using a one-stage random-effects model.</p><p><strong>Results: </strong>We identified 39,453 records after searching the databases. After combining the results of citation searches and reference checks of the guidelines, 45 studies were eligible. For the DRMA, we eliminated 14 studies without results and 15 with a critical risk of bias. We included 9587 patients from 16 studies. Our DRMA showed a non-linear risk curve, with odds ratio for HAI decreasing and reaching a trough at three units of RBC transfusion. Three units of RBC may not increase the risk of HAI in critically ill patients. However, the clinical implications of higher RBC transfusion volumes remain unclear.</p><p><strong>Conclusions: </strong>Our findings suggest a non-linear relationship between RBC transfusion volume and HAI risk in critically ill patients, highlighting the need for further research to inform individualized transfusion strategies. Clinical Trial Registration http://osf.io/a9cwd.</p>","PeriodicalId":16123,"journal":{"name":"Journal of Intensive Care","volume":"13 1","pages":"53"},"PeriodicalIF":4.7000,"publicationDate":"2025-09-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12486664/pdf/","citationCount":"0","resultStr":"{\"title\":\"Dose-response relationship between transfusion and the incidence of infection in critically ill patients: a systematic review and dose-response meta-analysis.\",\"authors\":\"Shodai Yoshihiro, Yuki Kataoka, Takashi Hongo, Takahiro Tsuge, Hiroaki Matsuo\",\"doi\":\"10.1186/s40560-025-00822-x\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Purpose: </strong>To estimate the association between red blood cell (RBC) transfusion volume and hospital-acquired infections (HAI) in critically ill patients, with a particular focus on identifying the potential threshold volumes at which infection risk changes.</p><p><strong>Methods: </strong>The MEDLINE, CENTRAL, Embase, and Transfusion Evidence Library databases were searched for studies published from database inception to November 2024. Citation searches and reference checks of the relevant guidelines were combined. Studies that evaluated transfusion and anemia pharmacotherapy in critically ill patients were included. Outcome of interest was the incidence of HAI. We conducted a dose-response meta-analysis (DRMA) using a one-stage random-effects model.</p><p><strong>Results: </strong>We identified 39,453 records after searching the databases. After combining the results of citation searches and reference checks of the guidelines, 45 studies were eligible. For the DRMA, we eliminated 14 studies without results and 15 with a critical risk of bias. We included 9587 patients from 16 studies. Our DRMA showed a non-linear risk curve, with odds ratio for HAI decreasing and reaching a trough at three units of RBC transfusion. Three units of RBC may not increase the risk of HAI in critically ill patients. However, the clinical implications of higher RBC transfusion volumes remain unclear.</p><p><strong>Conclusions: </strong>Our findings suggest a non-linear relationship between RBC transfusion volume and HAI risk in critically ill patients, highlighting the need for further research to inform individualized transfusion strategies. Clinical Trial Registration http://osf.io/a9cwd.</p>\",\"PeriodicalId\":16123,\"journal\":{\"name\":\"Journal of Intensive Care\",\"volume\":\"13 1\",\"pages\":\"53\"},\"PeriodicalIF\":4.7000,\"publicationDate\":\"2025-09-30\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12486664/pdf/\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Journal of Intensive Care\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1186/s40560-025-00822-x\",\"RegionNum\":2,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q1\",\"JCRName\":\"CRITICAL CARE MEDICINE\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Intensive Care","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1186/s40560-025-00822-x","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"CRITICAL CARE MEDICINE","Score":null,"Total":0}
Dose-response relationship between transfusion and the incidence of infection in critically ill patients: a systematic review and dose-response meta-analysis.
Purpose: To estimate the association between red blood cell (RBC) transfusion volume and hospital-acquired infections (HAI) in critically ill patients, with a particular focus on identifying the potential threshold volumes at which infection risk changes.
Methods: The MEDLINE, CENTRAL, Embase, and Transfusion Evidence Library databases were searched for studies published from database inception to November 2024. Citation searches and reference checks of the relevant guidelines were combined. Studies that evaluated transfusion and anemia pharmacotherapy in critically ill patients were included. Outcome of interest was the incidence of HAI. We conducted a dose-response meta-analysis (DRMA) using a one-stage random-effects model.
Results: We identified 39,453 records after searching the databases. After combining the results of citation searches and reference checks of the guidelines, 45 studies were eligible. For the DRMA, we eliminated 14 studies without results and 15 with a critical risk of bias. We included 9587 patients from 16 studies. Our DRMA showed a non-linear risk curve, with odds ratio for HAI decreasing and reaching a trough at three units of RBC transfusion. Three units of RBC may not increase the risk of HAI in critically ill patients. However, the clinical implications of higher RBC transfusion volumes remain unclear.
Conclusions: Our findings suggest a non-linear relationship between RBC transfusion volume and HAI risk in critically ill patients, highlighting the need for further research to inform individualized transfusion strategies. Clinical Trial Registration http://osf.io/a9cwd.
期刊介绍:
"Journal of Intensive Care" is an open access journal dedicated to the comprehensive coverage of intensive care medicine, providing a platform for the latest research and clinical insights in this critical field. The journal covers a wide range of topics, including intensive and critical care, trauma and surgical intensive care, pediatric intensive care, acute and emergency medicine, perioperative medicine, resuscitation, infection control, and organ dysfunction.
Recognizing the importance of cultural diversity in healthcare practices, "Journal of Intensive Care" also encourages submissions that explore and discuss the cultural aspects of intensive care, aiming to promote a more inclusive and culturally sensitive approach to patient care. By fostering a global exchange of knowledge and expertise, the journal contributes to the continuous improvement of intensive care practices worldwide.